[1] |
Xue YW, Song X, Fan SY, et al. The role of tumor-associated macrophages in oral squamous cell carcinoma[J]. Front Physiol, 2022, 13: 959747.
|
[2] |
Voss JO, Freund L, Neumann F, et al. Prognostic value of lymph node involvement in oral squamous cell carcinoma[J]. Clin Oral Investig, 2022, 26(11): 6711-6720.
|
[3] |
Eun YG, Lee JW, Kim SW, et al. Oral microbiome associated with lymph node metastasis in oral squamous cell carcinoma[J]. Sci Rep, 2021, 11(1): 23176.
|
[4] |
Bugshan A, Farooq I. Oral squamous cell carcinoma: Metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis[J]. F1000Res, 2020, 9: 229.
doi: 10.12688/f1000research.22941.1
pmid: 32399208
|
[5] |
Chai AWY, Lim KP, Cheong SC. Translational genomics and recent advances in oral squamous cell carcinoma[J]. Semin Cancer Biol, 2020, 61: 71-83.
doi: S1044-579X(19)30260-3
pmid: 31542510
|
[6] |
Lindemann A, Takahashi H, Patel AA, et al. Targeting the DNA damage response in OSCC with TP53 mutations[J]. J Dent Res, 2018, 97(6): 635-644.
doi: 10.1177/0022034518759068
pmid: 29489434
|
[7] |
Mohapatra P, Shriwas O, Mohanty S, et al. CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis[J]. JCI Insight, 2021, 6(4): e143643.
|
[8] |
Meng X, Lou QY, Yang WY, et al. The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential[J]. Cancer Commun (Lond), 2021, 41(10): 981-1006.
|
[9] |
Jang TH, Huang WC, Tung SL, et al. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway[J]. J Biomed Sci, 2022, 29(1): 42.
|
[10] |
Li R, Liu WZ, Ou L, et al. Emodin alleviates hydrogen peroxide-induced inflammation and oxidative stress via mitochondrial dysfunction by inhibiting the PI3K/mTOR/GSK3 β pathway in neuroblastoma SH-SY5Y cells[J]. Biomed Res Int, 2020, 2020: 1562915.
|
[11] |
Tuli HS, Aggarwal V, Tuorkey M, et al. Emodin: A metabolite that exhibits anti-neoplastic activities by modulating multiple oncogenic targets[J]. Toxicol In Vitro, 2021, 73: 105142.
|
[12] |
McDonald SJ, Vander Veen BN, Velazquez KT, et al. Therapeutic potential of emodin for gastrointestinal cancers[J]. Integr Cancer Ther, 2022, 21: 15347354211067469.
|
[13] |
Du L, Li YC, Liu WF. Maresin 1 regulates autophagy and inflammation in human periodontal ligament cells through glycogen synthase kinase-3β/β-catenin pathway under inflammatory conditions[J]. Arch Oral Biol, 2018, 87: 242-247.
doi: S0003-9969(17)30406-5
pmid: 29331511
|
[14] |
Wang F, Liao Y, Zhang M, et al. N6-methyladenosine demethyltransferase FTO-mediated autophagy in malignant development of oral squamous cell carcinoma[J]. Oncogene, 2021, 40(22): 3885-3898.
doi: 10.1038/s41388-021-01820-7
pmid: 33972683
|
[15] |
Onorati AV, Dyczynski M, Ojha R, et al. Targeting autophagy in cancer[J]. Cancer, 2018, 124(16): 3307-3318.
doi: 10.1002/cncr.31335
pmid: 29671878
|
[16] |
Saikishore R, Velmurugan P, Ranjithkumar D, et al. The circular RNA-miRNA axis: A special RNA signature regulatory transcriptome as a potential biomarker for OSCC[J]. Mol Ther Nucleic Acids, 2020, 22: 352-361.
|
[17] |
Gou QT, Zheng LL, Huang HX. Unravelling the roles of Autophagy in OSCC: A renewed perspective from mechanisms to potential applications[J]. Front Pharmacol, 2022, 13: 994643.
|
[18] |
Pignatelli P, Romei FM, Bondi D, et al. Microbiota and oral cancer as A complex and dynamic microenvironment: A narrative review from etiology to prognosis[J]. Int J Mol Sci, 2022, 23(15): 8323.
|
[19] |
Tang X, Hu YJ, Ju WT, et al. Elevated growth differentiating factor 15 expression predicts long-term benefit of docetaxel, cisplatin and 5-fluorouracil induction chemotherapy in patients with oral cancer[J]. Oncol Lett, 2018, 15(5): 8118-8124.
doi: 10.3892/ol.2018.8324
pmid: 29731919
|
[20] |
Yi L, Liu JF, Deng M, et al. Emodin inhibits viability, proliferation and promotes apoptosis of hypoxic human pulmonary artery smooth muscle cells via targeting miR-244-5p/DEGS1 axis[J]. BMC Pulm Med, 2021, 21(1): 252.
|
[21] |
Li WL, Wang D, Li MJ, et al. Emodin inhibits the proliferation of papillary thyroid carcinoma by activating AMPK[J]. Exp Ther Med, 2021, 22(4): 1075.
|
[22] |
Dai GL, Wang D, Ma ST, et al. ACSL4 promotes colorectal cancer and is a potential therapeutic target of emodin[J]. Phytomedicine, 2022, 102: 154149.
|
[23] |
Ariosa AR, Lahiri V, Lei YC, et al. A perspective on the role of autophagy in cancer[J]. Biochim Biophys Acta Mol Basis Dis, 2021, 1867(12): 166262.
|
[24] |
Jiang HB, Cheng DM, Liu WH, et al. Protein kinase C inhibits autophagy and phosphorylates LC3[J]. Biochem Biophys Res Commun, 2010, 395(4): 471-476.
|